Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254795 · ClinicalTrials.gov registry record · NA
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care
A NA study of Non-Small Cell Lung Cancer, sponsored by Timothy Mullett.
- Active
- Registry status
- NA
- Development phase
- 659
- Enrollment target
- 1
- Study location
NCT05254795 is a NA study of Non-Small Cell Lung Cancer that is active but no longer recruiting, run by Timothy Mullett. The registered enrollment target is 659 participants, roughly in line with the 657-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05254795, a NA study of Non-Small Cell Lung Cancer, is active but no longer recruiting, sponsored by Timothy Mullett.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 659 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will compare Molecular Tumor Board (MTB) assisted care to usual care for patients who have newly diagnosed histologically or cytologically confirmed stage IIb-IV Non-Small Cell Lung Cancer (NSCLC) and are planning to undergo treatment for their cancer.
Conditions Studied
Interventions
- OTHER Molecular tumor board assisted care
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 659 participants |
| Start Date | 2022-04-13 |
| Est. Completion | 2026-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05254795
The ClinicalTrials.gov registry entry for NCT05254795 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 659 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 657-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target. The listed sponsor is Timothy Mullett, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Molecular tumor board assisted care is the first listed.
NCT05254795 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05254795 about?
NCT05254795 is a clinical study titled "Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care". This trial will compare Molecular Tumor Board (MTB) assisted care to usual care for patients who have newly diagnosed histologically or cytologically confirmed stage IIb-IV Non-Small Cell Lung Cancer (NSCLC) and are planning to undergo treatment for their cancer.
What is the current status of trial NCT05254795?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 659 participants. The study started on 2022-04-13. Estimated completion is 2026-12-22.
What conditions does trial NCT05254795 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
What interventions are being tested in trial NCT05254795?
The interventions under investigation include: Molecular tumor board assisted care (OTHER).
Who is sponsoring clinical trial NCT05254795?
This trial is sponsored by Timothy Mullett, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05254795 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
RECRUITING · NA
-
High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.